Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2021-09-13 00:00:00 ET · period of report 2021-09-10 · accession 0001628280-21-018433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-13 | 2021-09-10 | CRDF | Levine James E. | CFO | P - Purchase | $6.47 | +30.0K | 30.0K | New | +$194.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-10 | P | A | 5,000 | $6.62 | 5,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-10 | P | A | 5,000 | $6.75 | 10,000 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-10 | P | A | 10,000 | $6.38 | 20,000 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-10 | P | A | 5,000 | $6.35 | 25,000 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-10 | P | A | 5,000 | $6.32 | 30,000 | D | — | — |